ThINC-3 conference brings international experts together for a day with presentations on overdose prevention and take-home Naloxone.
Themes include:
- Local experiences and common challenges
- Existing and growing target groups
- What works? The current evidence base
- The international perspective: main challenges and trends
The target group for the conference is national and international researchers, clinicians, decision makers, and clinic managers, among others.
Please note: the conference will be held in English.
Participation is free, but registration is required.
|
Time |
Presentation |
Speaker |
|
8:30-9:00 |
Registration & Coffee |
|
|
9:00-9:10 |
Welcome |
Thomas Clausen |
|
Session 1: Local experience and common challenges |
||
|
9:10-9:25 |
10 years of experience with THN in Norway |
Desiree Eide |
|
9:25-9:40 |
Implementation of THN: barriers, successes, and opportunities |
Alexander Walley |
|
9:40-9:55 |
THN research: challenges in documenting the effects |
John Strang |
|
9:55-10:10 |
Questions |
|
|
10:10-10:30 |
Coffee and refreshments |
|
|
Session 2: Existing and emerging target groups |
||
|
10:30-10:45 |
THN perspectives from people who use drugs |
Arild Knutsen |
|
10:45-11:00 |
Prescribed opioids and the role of THN |
Ingrid Binswanger |
|
11:00-11:15 |
THN: Whom to target? |
Rebecca McDonald |
|
11:15-11:30 |
Questions |
|
|
11:30-12:30 |
Lunch |
|
|
Session 3: What is working? The current evidence base |
||
|
12:30-12:45 |
THN models for different populations and settings |
Suzanne Nielsen |
|
12:45-13:00 |
Best practices for THN programs |
Alex Kral |
|
13:00-13:15 |
Rethinking “withdrawal” after an overdose reversal |
Joanne Neale |
|
13:15-13:30 |
Questions |
|
|
13:30-13:50 |
Coffee and refreshments |
|
|
Session 4: The international perspective: Main challenges and trends |
||
|
13:50-14:05 |
Scotland |
Andrew McAuley |
|
14:05-14:20 |
Sweden |
Katja Troberg |
|
14:20-14:35 |
USA |
Traci Green |
|
14:35-14:50 |
Questions |
|
|
14:50-15:30 |
Discussion and closing remarks |
|
The conference is arranged by SERAF with support from the Norwegian Directorate of Health Overdose Strategy.